Patent ID: 11858913
Assignee: ALIGOS THERAPEUTICS, INC.
Field: Organic fine chemistry (Chemistry)
Classification: CPC C  A | IPC C

Claim 6:
7. The compound of claim 1, or a stereoisomer or a tautomer thereof, or a pharmaceutically acceptable salt thereof, wherein R3 and R4 are each independently selected from halogen; —CN; C1-C3 alkyl optionally substituted with 1 to 3 substituents independently selected from halogen and C1-C6 alkoxy; C1-C2 alkoxy optionally substituted with 1 to 3 substituents independently selected from halogen; and C2-C3 alkenyl optionally substituted with 1 to 3 substituents independently selected from halogen and C1-C6 alkoxy; and cyclopropyl.